Citation Tools

Download PDFPDF

720 A phase 1/2 study of BDC-3042, a novel Dectin-2 agonistic antibody, in patients with advanced cancers

Download to a citation manager

Cite this article as:
Giordano A, Dumbrava E, Parikh AR, et al
720 A phase 1/2 study of BDC-3042, a novel Dectin-2 agonistic antibody, in patients with advanced cancers